Authors: PENTIKIS HS MULLIN ME HOWARD M BOUTOUYRIE S RHODES G

Citation: Hs. Pentikis et al., EVALUATION OF THE BIOAVAILABILITY AND DOSE PROPORTIONALITY OF 3 FORMULATIONS OF A COMBINATION ESTROGEN AND PROGESTIN ADHESIVE-BASED MATRIX TRANSDERMAL, DELIVERY SYSTEM, Current therapeutic research, 59(10), 1998, pp. 681-691

Authors: PENTIKIS HS MULLIN ME RHODES G BRUNO R

Citation: Hs. Pentikis et al., THE USE OF A REGRESSION APPROACH TO PREDICT E2 AND NET EXPOSURE FROM LIMITED SAMPLING DURING A PHASE-III TRIAL OF COMBI-PATCH, A NEW COMBINATION TRANSDERMAL DELIVERY SYSTEM, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 112-112

Authors: LUDDEN LK LUDDEN TM COLLINS JM PENTIKIS HS STRONG JM

Citation: Lk. Ludden et al., EFFECT OF ALBUMIN ON THE ESTIMATION, IN-VITRO, OF PHENYTOIN V-MAX ANDK-M VALUES - IMPLICATIONS FOR CLINICAL CORRELATION, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 391-396

Authors: PENTIKIS HS HENDERSON JD TRAN NL LUDDEN TM

Citation: Hs. Pentikis et al., BIOEQUIVALENCE - INDIVIDUAL AND POPULATION COMPARTMENTAL MODELING COMPARED TO THE NONCOMPARTMENTAL APPROACH, Pharmaceutical research, 13(7), 1996, pp. 1116-1121

Authors: LUDDEN LK PENTIKIS HS LUDDEN TM COLLINS JM STRONG JM

Citation: Lk. Ludden et al., THE ADDITION OF ALBUMIN, IN-VITRO, YIELDS MEANINGFUL FREE DRUG KM VALUES FOR PHENYTOIN METABOLISM, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 45-45

Authors: PENTIKIS HS JOHNSON RD HUANG MY JENSEN BK HEALD DL DORR MB TALBOT GH

Citation: Hs. Pentikis et al., POPULATION PHARMACOKINETIC ANALYSIS OF SPARFLOXACIN PLASMA-CONCENTRATIONS OBTAINED IN PHASE-III CLINICAL-TRIALS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 70-70